Companies
- Stryker CorporationBoard member Dec 3, 2020 to now9
- Bristol-Myers SquibbBoard member Jun 2014 to now10
- Bristol-Myers SquibbChair May 9, 2017 to Mar 12, 202411
- Bristol-Myers SquibbChief executive officer May 2015 to Nov 3, 202312
- Bristol-Myers SquibbChief operating officer Sep 16, 2014 to Mar 12, 201513
- Bristol-Myers SquibbPres., US Pharmaceuticals Oct 27, 2011 to Mar 12, 201414
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY432,266 shares15$26.3M at $60.95Mar 10, 2024
Stryker Corporation SYK4,530 shares16$1.3M at $296.45May 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 6, 2026Granted 762 shares of Stryker Corporation16
- May 8, 2025Granted 560 shares of Stryker Corporation17
- May 9, 2024Granted 653 shares of Stryker Corporation18
- Mar 10, 2024Shares withheld for tax 47,651 shares at $53.79 of Bristol-Myers Squibb15
- Mar 10, 2024Other 49,745 shares of Bristol-Myers Squibb15
- Mar 10, 2024Exercised options 142,904 shares of Bristol-Myers Squibb15
- Mar 10, 2024Shares withheld for tax 10,084 shares at $53.79 of Bristol-Myers Squibb15
- Mar 10, 2024Other 4,104 shares of Bristol-Myers Squibb15
- Mar 10, 2024Exercised options 23,817 shares of Bristol-Myers Squibb15
- Mar 10, 2024Shares withheld for tax 10,088 shares at $53.79 of Bristol-Myers Squibb15
- Mar 10, 2024Other 3,687 shares of Bristol-Myers Squibb15
- Mar 10, 2024Exercised options 23,409 shares of Bristol-Myers Squibb15
- Oct 10, 2023Gift 440 shares of Bristol-Myers Squibb19
- May 10, 2023Granted 705 shares of Stryker Corporation20
- May 4, 2023Exercised options 841 shares of Stryker Corporation21
- Mar 10, 2023Shares withheld for tax 80,594 shares at $65.71 of Bristol-Myers Squibb22
- Mar 10, 2023Other 17,148 shares of Bristol-Myers Squibb22
- Mar 10, 2023Exercised options 140,445 shares of Bristol-Myers Squibb22
- Mar 10, 2023Shares withheld for tax 11,728 shares at $65.71 of Bristol-Myers Squibb22
- Mar 10, 2023Other 718 shares of Bristol-Myers Squibb22
- Mar 10, 2023Exercised options 22,214 shares of Bristol-Myers Squibb22
- Mar 10, 2023Shares withheld for tax 14,179 shares at $65.71 of Bristol-Myers Squibb22
- Mar 10, 2023Other 3,908 shares of Bristol-Myers Squibb22
- Mar 10, 2023Exercised options 23,817 shares of Bristol-Myers Squibb22
- Mar 10, 2023Shares withheld for tax 14,184 shares at $65.71 of Bristol-Myers Squibb22
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | BMY | Sale | $17.9M | −19.8% | +108.2% | +54.4% |
| Sep 20, 2022 | BMY | Sale | $1.7M | −14.3% | +115.3% | +29.9% |
| Sep 15, 2022 | BMY | Sale | $3.6M | −16.8% | +114.6% | +31.4% |
| Jun 13, 2022 | BMY | Sale | $2.2M | −18.8% | +124.6% | +28.4% |
| Mar 21, 2022 | BMY | Sale | $1.8M | −15.9% | +89.6% | −5.3% |
| Feb 24, 2022 | BMY | Sale | $2.0M | −11.0% | +91.2% | −12.0% |
| Sep 20, 2021 | BMY | Sale | $1.5M | −1.2% | +79.1% | −26.8% |
| Aug 2, 2021 | BMY | Sale | $1.4M | −12.2% | +88.5% | −14.5% |
| Mar 22, 2021 | BMY | Sale | $1.6M | −5.7% | +102.3% | +2.8% |
| Aug 31, 2020 | BMY | Sale | $2.5M | −3.9% | +124.9% | +21.8% |
Returns are price-only (no dividends), measured from the trade date.
Early life and education
Career
Occupation: executive, physician.6
- Since 2015Chief executive, Bristol-Myers Squibb4
- Since 2014Board member, Bristol-Myers Squibb5
Personal life
- CitizenshipItaly7
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataGiovanni Caforio on Wikidata
- 2
- 3Wikidataeducation, as reported
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARStryker Corporation, Board member
- 10Wikidata and SEC EDGARBristol-Myers Squibb, Board member
- 11SEC EDGARBristol-Myers Squibb, Chair
- 12Wikidata and SEC EDGARBristol-Myers Squibb, Chief executive officer
- 13
- 14
- 15
- 16
- 17SEC EDGARForm 4 filed May 12, 2025
- 18SEC EDGARForm 4 filed May 13, 2024
- 19SEC EDGARForm 4 filed Oct 12, 2023
- 20SEC EDGARForm 4 filed May 12, 2023
- 21SEC EDGARForm 4 filed May 8, 2023
- 22SEC EDGARForm 4 filed Mar 14, 2023